Diagnostics Market Research Reports & Industry Analysis
The global diagnostics industry plays a critical role in disease prevention, detection, and treatment across a wide range of medical fields—and it’s also a big business with significant opportunities for growth and innovation. As the industry continues to change, staying up to date on the latest trends and insights is essential.
New Diagnostics Industry Reports Produced by Industry Experts
To help organizations understand the market on a deeper level and better navigate the shifting business landscape, MarketResearch.com offers a wide range of diagnostics market research reports. These studies cover both the in vitro diagnostics and medical imaging segments, providing information on market sizing, growth forecasts, market share, mergers and acquisitions, new product development, competitive analysis, and corporate profiling. With coverage of disruptive trends and emerging technologies, our reports give you the knowledge you need to stay ahead of market changes.
What Are the Benefits of Using MarketResearch.com?
- At MarketResearch.com, we understand the value of timely and reliable research. With over 20 years of experience in the field of market research, we have become a leading source of insights and analysis.
- We bring together reports from hundreds of leading firms, making it easy to find the information you need in one place.
- Our knowledgeable research specialists have worked closely with many top diagnostics industry companies and can offer personalized assistance to help you find reports that fit your research requirements.
- With our comprehensive coverage and expert analysis, you will be better positioned to gain a competitive edge in the global diagnostics industry.
Diagnostics Industry Research & Market Reports
-
Life Science Instrumentation
... at a CAGR of 4.6% over the analysis period 2024-2030. Spectroscopy, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$24.4 Billion by the end of the ... Read More
-
X-Ray Photoelectron Spectroscopy
... at a CAGR of 4.8% over the analysis period 2024-2030. Healthcare, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$339.2 Million by the end of the ... Read More
-
Exocrine Pancreatic Insufficiency
... at a CAGR of 5.8% over the analysis period 2024-2030. Therapeutics, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$4.8 Billion by the end of the ... Read More
-
Veterinary CT Scanners
... at a CAGR of 5.3% over the analysis period 2024-2030. Stationary Multi Slice, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$175.7 Million by the end ... Read More
-
Women`s Health Diagnostics
... at a CAGR of 5.8% over the analysis period 2024-2030. Breast Cancer Testing, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$11.3 Billion by the end ... Read More
-
MRI Compatible Pacemaker
... at a CAGR of 4.0% over the analysis period 2024-2030. Arrhythmias, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.5 Billion by the end of the ... Read More
-
Hemostasis Products
... CAGR of 3.7% over the analysis period 2024-2030. Infusible Hemostasis, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$8.6 Billion by the end of the analysis ... Read More
-
Zika Virus Testing
... at a CAGR of 5.8% over the analysis period 2024-2030. Molecular Testing, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$192.4 Million by the end of ... Read More
-
Acute Ischemic Stroke Diagnosis and Treatment
... reach US$3.1 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Computed Tomography, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach ... Read More
-
Vendor Neutral Archive (VNA) and PACS
... reach US$6.5 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. PACS, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$4.4 ... Read More
-
Ophthalmic Ultrasound Systems
... at a CAGR of 3.9% over the analysis period 2024-2030. Portable, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$2.4 Billion by the end of the ... Read More
-
Rapid Medical Diagnostic Kits
... 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Over the Counter (OTC) Kits, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$10.7 ... Read More
-
Testing and Analysis Services
... 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Elemental, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$12.4 Billion by the end ... Read More
-
Toxicology Testing Services
... at a CAGR of 8.4% over the analysis period 2024-2030. In Vivo Method, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$10.2 Billion by the end ... Read More
-
Umbilical Cord Blood Banking
... 2030, growing at a CAGR of 10.1% over the analysis period 2024-2030. Public Cord Blood Banks, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$4.3 Billion ... Read More
-
Lung Cancer Diagnostics
... at a CAGR of 7.8% over the analysis period 2024-2030. Imaging Tests, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$2.3 Billion by the end of ... Read More
-
Reporter Gene Assays
... at a CAGR of 6.5% over the analysis period 2024-2030. Luciferase Assays, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$4.6 Billion by the end of ... Read More
-
Direct-to-Consumer (DTC) Genetic Testing
... 2030, growing at a CAGR of 14.0% over the analysis period 2024-2030. Single Nucleotide Polymorphism (SNP) Chips, one of the segments analyzed in the report, is expected to record a 13.6% CAGR and reach US$1.6 ... Read More
-
Clinical Laboratory Services
... at a CAGR of 5.3% over the analysis period 2024-2030. Clinical Chemistry, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$163.3 Billion by the end of ... Read More
-
Full Body Scanners
... at a CAGR of 11.3% over the analysis period 2024-2030. Millimeter, one of the segments analyzed in the report, is expected to record a 11.7% CAGR and reach US$609.0 Million by the end of the ... Read More
-
Contrast Media
... CAGR of 3.2% over the analysis period 2024-2030. Barium-based Contrast Media, one of the segments analyzed in the report, is expected to record a 2.1% CAGR and reach US$305.4 Million by the end of the ... Read More
-
Diagnostic Imaging
... CAGR of 5.1% over the analysis period 2024-2030. X-ray Imaging, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$9.4 Billion by the end of the analysis ... Read More
-
Linear Motion Systems
... at a CAGR of 6.1% over the analysis period 2024-2030. Material Handling Equipment, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$1.8 Billion by the end ... Read More
-
Portable Ultrasound Equipment
... at a CAGR of 5.9% over the analysis period 2024-2030. Cart / Trolley-Based, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$2.4 Billion by the end ... Read More
-
Vendor Neutral Archives
... at a CAGR of 6.5% over the analysis period 2024-2030. On-Premises, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$552.5 Million by the end of the ... Read More
Research Assistance
